Skip to main content
Year archive

CAMBIUM BIO LIMITED — 2018 filings

All 33 regulatory filings released by CAMBIUM BIO LIMITED (CMB) in 2018, sourced directly from the official regulator.

33 Filings
2018 Period
2018 filings (33)
Filing Released Lang
Chinese patent granted for biomarkers for stem cell therapy 2 pages 75.4KB
Regulatory Filings
2018-12-02 English
Chairman's Address to Shareholders 3 pages 63.1KB
AGM Information
2018-11-21 English
CEO Presentation to 2018 Annual General Meeting 39 pages 1.6MB
AGM Information
2018-11-21 English
Results of Annual General Meeting 2 pages 415.2KB
Declaration of Voting Results & Voting Rights Announcements
2018-11-21 English
Presentation for AusBiotech 2018 20 pages 1.1MB
Investor Presentation
2018-10-30 English
Appendix 4C - Quarterly 6 pages 238.7KB
Interim / Quarterly Report
2018-10-23 English
Re-Released - Appendix 4C - Quarterly 6 pages 238.7KB
Interim / Quarterly Report
2018-10-23 English
Notice of Annual General Meeting / Proxy Form 13 pages 875.1KB
AGM Information
2018-10-18 English
Progenza patent to grant in Europe 2 pages 92.0KB
Regulatory Filings
2018-10-17 English
Appendix 3Y Change of Director's Interest Notice 4 pages 302.8KB
Director's Dealing
2018-09-18 English
Date of AGM 1 page 381.7KB
Regulatory Filings
2018-09-17 English
Regeneus receives R&D tax incentive refund of $2.4m 1
Capital/Financing Update
2018-09-05 English
Appendix 4E 2 pages 903.6KB
Regulatory Filings
2018-08-29 English
Annual Report 2018 50 pages 2.0MB
Annual Report
2018-08-29 English
Appendix 4G and Corporate Governance Statement 18 pages 332.4KB
Governance Information
2018-08-29 English
FY18 Results and Business Update Presentation 29 pages 1.6MB
Investor Presentation
2018-08-29 English
FY18 Results and Business Update 4 pages 145.5KB
Annual Report
2018-08-29 English
Positive clinical trial results for cancer vaccine 2 pages 124.7KB
Regulatory Filings
2018-07-29 English
Appendix 4C - Quarterly 6 pages 232.0KB
Interim / Quarterly Report
2018-07-24 English
Response to ASX Price Query 4 pages 1.0MB
Regulatory Filings
2018-07-22 English
US Patent Office to allow key patent for Progenza 2 pages 103.4KB
Regulatory Filings
2018-07-09 English
Update on licensing Progenza in Japan 1 page 99.6KB
Capital/Financing Update
2018-07-02 English
Grant of ASX Waiver 2 pages 165.6KB
Capital/Financing Update
2018-06-27 English
Appendix 4C - Quarterly 6 pages 3.4MB
Regulatory Filings
2018-04-25 English
Appendix 3Y Change of Director's Interest Notice 2 pages 220.2KB
Director's Dealing
2018-04-19 English
Positive trial results of Progenza for knee OA published 15 pages 1.6MB
Regulatory Filings
2018-03-06 English
Appendix 4D and Half-Year Report 23 pages 1.1MB
Interim / Quarterly Report
2018-02-19 English
Half-Year Results Announcement 2 pages 115.5KB
Interim / Quarterly Report
2018-02-19 English
Half-Year Results Presentation 17 pages 654.2KB
Interim / Quarterly Report
2018-02-19 English
European Medicines Agency grants Progenza ATMP status 2 pages 107.0KB
Regulatory Filings
2018-02-13 English
Japanese Patent Office to grant patent for cancer vaccine 2 pages 109.9KB
Regulatory Filings
2018-02-11 English
Regeneus Announces Successful Results in Acne Study 2 pages 137.9KB
Regulatory Filings
2018-02-05 English
Appendix 4C - Quarterly 6 pages 3.5MB
Regulatory Filings
2018-01-24 English